State Board of Administration of Florida Retirement System reduced its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 8.9% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 160,065 shares of the biotechnology company’s stock after selling 15,637 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Biogen […]
Biogen (NASDAQ:BIIB – Get Free Report) will be announcing its earnings results before the market opens on Tuesday, February 13th. Analysts expect the company to announce earnings of $3.16 per share for the quarter. Biogen has set its FY23 guidance at $14.50-15.00 EPS.Investors that are interested in participating in the company’s conference call can do […]
Virtus ETF Advisers LLC decreased its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 11.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,016 shares of the biotechnology company’s stock after selling 129 shares during the quarter. Virtus ETF Advisers LLC’s […]
Wealthspire Advisors LLC acquired a new position in Biogen Inc. (NASDAQ:BIIB – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 2,369 shares of the biotechnology company’s stock, valued at approximately $609,000. Other large investors have also recently modified their […]
Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at Oppenheimer in a note issued to investors on Tuesday, Benzinga reports. They currently have a $295.00 target price on the biotechnology company’s stock. Oppenheimer’s price objective points to a potential upside of 19.25% from the stock’s previous close. BIIB […]